SynthesisBMC pulmonary medicine2024

What is the optimal first-line regimen for advanced non-small cell lung cancer patients with epidermal growth factor receptor mutation: a systematic review and network meta-analysis.

Wengang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.